Insider trading

Period: 12 months Stock: PAYS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

19 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

19 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

19 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

19 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
19 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
19 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

19 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Sep 2026
Herman Joan M EVP, Operations
Sold on a plan
$456.83K 38,900 at 11.74
6.0%
Planned (10b5-1)
15 Sep 2026
Herman Joan M EVP, Operations
Sold on a plan
$260.07K 21,004 at 12.38
3.1%
Planned (10b5-1)
9 Sep 2026
Ngo Michael C Chief Innovation Officer · indirect
Sold at will
$1.02M 79,925 at 12.74
3.3%
Not planned
8 Sep 2026
Ngo Michael C Chief Innovation Officer · indirect
Sold at will
$900.42K 70,075 at 12.85
2.8%
Not planned
12 Aug 2026
Baker Jeffery Bradford Chief Financial Officer
Sold at will
$441.64K 35,000 at 12.62
6.1%
Not planned
6 Aug 2026
Sold on a plan
$1.78M 150,000 at 11.88
1.6%
Planned (10b5-1)
29 Jul 2026
Sold on a plan
$468.99K 50,000 at 9.38
0.5%
Planned (10b5-1)
16 Jul 2026
Herman Joan M EVP, Operations
Sold on a plan
$243.41K 28,000 at 8.69
4.1%
Planned (10b5-1)
15 Jul 2026
Herman Joan M EVP, Operations
Sold on a plan
$274.25K 31,904 at 8.60
4.5%
Planned (10b5-1)
26 Jun 2026
Herman Joan M EVP, Operations
Sold on a plan
$801.14K 100,000 at 8.01
12.4%
Planned (10b5-1)
11 Jun 2026
Mina Bruce A Director
Sold at will
$70.95K 10,000 at 7.10
3.7%
Not planned
1 Jun 2026
Herman Joan M EVP, Operations
Sold on a plan
$233.73K 29,202 at 8.00
3.5%
Planned (10b5-1)
1 Jun 2026
Mina Bruce A Director
Sold at will
$71.00K 10,000 at 7.10
3.6%
Not planned
1 Jun 2026
Cunningham Bradley Kramer Chief Technology Officer
Sold at will
$23.40K 3,000 at 7.80
0.9%
Not planned
29 May 2026
Cunningham Bradley Kramer Chief Technology Officer
Sold at will
$73.02K 10,000 at 7.30
2.8%
Not planned
26 May 2026
Herman Joan M EVP, Operations
Sold on a plan
$158.04K 22,534 at 7.01
2.7%
Planned (10b5-1)
4 May 2026
Herman Joan M EVP, Operations
Sold on a plan
$46.74K 6,667 at 7.01
0.8%
Planned (10b5-1)
3 Feb 2026
Turner Matthew Baker PRES., PATIENT AFFORDABILITY
Sold at will
$62.64K 15,057 at 4.16
3.2%
Not planned
12 Dec 2025
Strobo Robert Chief Legal Officer
Sold at will
$109.40K 20,000 at 5.47
5.8%
Not planned
Showing 1–19 of 19.